N-(5-Bromo-2,3-dihydro-1H-inden-4-yl)pivalamide

Catalog No. :
ACKAPD130
CAS No. :
2142576-66-5
Molecular Formula :
C14H18BrNO
Molecular Weight :
296.21

IUPAC Name:N-(5-bromo-2,3-dihydro-1H-inden-4-yl)pivalamide

N-(5-Bromo-2,3-dihydro-1H-inden-4-yl)pivalamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$94.00Login to see priceInquiryInquiry
1g97%$156.00Login to see priceInquiryInquiry
5g97%$768.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(5-Bromo-2,3-dihydro-1H-inden-4-yl)pivalamide
IUPAC NameN-(5-bromo-2,3-dihydro-1H-inden-4-yl)pivalamide
MDL No.-
Molecular FormulaC14H18BrNO
Molecular Weight296.21
SMILESO=C(C(C)(C)C)NC1=C(CCC2)C2=CC=C1Br
InChI KeyXRQXBSLPSXPEHC-UHFFFAOYSA-N
SynonymPropanamide, N-(5-bromo-2,3-dihydro-1H-inden-4-yl)-2,2-dimethyl-;N-(5-Bromo-2,3-dihydro-1H-inden-4-yl)pivalamide;N-(5-Bromo-4-indanyl)pivalamide
CAS No.2142576-66-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKAPD130 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKNAC376 route compound structure diagram
    ACKNAC3762260959-47-3 In Stock
  4. Then
  5. ACKAPD130 route product structure diagram
    ACKAPD1302142576-66-5
Inquiry

2. ACKAPD130 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCRFX132 route compound structure diagram
    ACCRFX1322964572-05-0 In Stock
  2. Plus
  3. ACKNAC376 route compound structure diagram
    ACKNAC3762260959-47-3 In Stock
  4. Then
  5. ACKAPD130 route product structure diagram
    ACKAPD1302142576-66-5
Inquiry

Comments (0)